145 related articles for article (PubMed ID: 30911614)
1. Electrostatic precipitation Pressurized IntraPeritoneal Aerosol Chemotherapy (ePIPAC): first in-human application.
Reymond M; Demtroeder C; Solass W; Winnekendonk G; Tempfer C
Pleura Peritoneum; 2016 Jun; 1(2):109-116. PubMed ID: 30911614
[No Abstract] [Full Text] [Related]
2. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient.
Graversen M; Detlefsen S; Ellebaek SB; Fristrup C; Pfeiffer P; Mortensen MB
Eur J Surg Oncol; 2020 Jan; 46(1):155-159. PubMed ID: 31493986
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC).
Kakchekeeva T; Demtröder C; Herath NI; Griffiths D; Torkington J; Solaß W; Dutreix M; Reymond MA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):592-598. PubMed ID: 26842487
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Van de Sande L; Willaert W; Cosyns S; De Clercq K; Shariati M; Remaut K; Ceelen W
BMC Cancer; 2019 May; 19(1):424. PubMed ID: 31064330
[TBL] [Abstract][Full Text] [Related]
5. Pressurized Intraperitoneal Aerosol Chemotherapy Enhanced by Electrostatic Precipitation (ePIPAC) for Patients with Peritoneal Metastases.
Taibi A; Teixeira Farinha H; Durand Fontanier S; Sayedalamin Z; Hübner M; Sgarbura O
Ann Surg Oncol; 2021 Jul; 28(7):3852-3860. PubMed ID: 33216263
[TBL] [Abstract][Full Text] [Related]
6. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.
Roussin F; Taibi A; Canal-Raffin M; Cantournet L; Durand-Fontanier S; Druet-Cabanac M; El Balkhi S; Maillan G
Eur J Surg Oncol; 2021 Nov; 47(11):2939-2947. PubMed ID: 34034944
[TBL] [Abstract][Full Text] [Related]
7. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
[TBL] [Abstract][Full Text] [Related]
8. The effect of electrostatic high pressure nebulization on the stability, activity and ex vivo distribution of ionic self-assembled nanomedicines.
Braet H; Andretto V; Mariën R; Yücesan B; van der Vegte S; Haegebaert R; Lollo G; De Smedt SC; Remaut K
Acta Biomater; 2023 Oct; 170():318-329. PubMed ID: 37598790
[TBL] [Abstract][Full Text] [Related]
9. Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
Lurvink RJ; Tajzai R; Rovers KP; Wassenaar ECE; Moes DAR; Pluimakers G; Boerma D; Burger JWA; Nienhuijs SW; de Hingh IHJT; Deenen MJ
Ann Surg Oncol; 2021 Jan; 28(1):265-272. PubMed ID: 32572849
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Graversen M; Detlefsen S; Bjerregaard JK; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2017 Jun; 34(5):309-314. PubMed ID: 28516306
[TBL] [Abstract][Full Text] [Related]
11. First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).
Rauwerdink P; van de Vlasakker VCJ; Wassenaar ECE; Rovers KP; Los M; Herbschleb KH; Creemers GM; Thijs AMJ; Raicu MG; Huysentruyt CJR; van der Hoeven EJRJ; Nederend J; Peeters RYM; Deenen MJ; Elias SG; Fijneman RJA; Constantinides A; Kranenburg O; Burger PWA; Nienhuijs SW; Wiezer RJ; Lurvink RJ; de Hingh IHJT; Boerma D
Eur J Surg Oncol; 2024 Jun; 50(9):108487. PubMed ID: 38905732
[TBL] [Abstract][Full Text] [Related]
12. Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma.
Di Giorgio A; Sgarbura O; Rotolo S; Schena CA; Bagalà C; Inzani F; Russo A; Chiantera V; Pacelli F
Ther Adv Med Oncol; 2020; 12():1758835920940887. PubMed ID: 32782488
[TBL] [Abstract][Full Text] [Related]
13. Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy.
Somashekhar SP; Ashwin KR; Rauthan CA; Rohit KC
Pleura Peritoneum; 2018 Sep; 3(3):20180110. PubMed ID: 30911661
[TBL] [Abstract][Full Text] [Related]
14. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
[TBL] [Abstract][Full Text] [Related]
15. Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study.
Kurtz F; Struller F; Horvath P; Solass W; Bösmüller H; Königsrainer A; Reymond MA
Gastroenterol Res Pract; 2018; 2018():2743985. PubMed ID: 30473706
[TBL] [Abstract][Full Text] [Related]
16. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer.
Rezniczek GA; Giger-Pabst U; Thaher O; Tempfer CB
BMC Cancer; 2020 Nov; 20(1):1122. PubMed ID: 33213407
[TBL] [Abstract][Full Text] [Related]
17. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A case report of a multimodal treatment for peritoneal metastases of pancreatic origin.
Rotolo S; Ferracci F; Santullo F; Lodoli C; Inzani F; Abatini C; Pacelli F; Di Giorgio A
Int J Surg Case Rep; 2020; 77S(Suppl):S75-S78. PubMed ID: 33191190
[TBL] [Abstract][Full Text] [Related]
18. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.
Struller F; Horvath P; Solass W; Weinreich FJ; Strumberg D; Kokkalis MK; Fischer I; Meisner C; Königsrainer A; Reymond MA
Ther Adv Med Oncol; 2019; 11():1758835919846402. PubMed ID: 31205501
[TBL] [Abstract][Full Text] [Related]
19. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
[TBL] [Abstract][Full Text] [Related]
20. Low-dose pressurized intraperitoneal aerosol chemotherapy (PIPAC) as an alternative therapy for ovarian cancer in an octogenarian patient.
Giger-Pabst U; Solass W; Buerkle B; Reymond MA; Tempfer CB
Anticancer Res; 2015 Apr; 35(4):2309-14. PubMed ID: 25862894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
